| IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors N Cieri, B Camisa, F Cocchiarella, M Forcato, G Oliveira, E Provasi, ... Blood, The Journal of the American Society of Hematology 121 (4), 573-584, 2013 | 670 | 2013 |
| Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis F Ciceri, L Beretta, AM Scandroglio, S Colombo, G Landoni, A Ruggeri, ... Critical care and resuscitation 22 (2), 95-97, 2020 | 668 | 2020 |
| Loss of mismatched HLA in leukemia after stem-cell transplantation L Vago, SK Perna, M Zanussi, B Mazzi, C Barlassina, MTL Stanghellini, ... New England Journal of Medicine 361 (5), 478-488, 2009 | 564 | 2009 |
| Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase … F Ciceri, C Bonini, MTL Stanghellini, A Bondanza, C Traversari, ... The lancet oncology 10 (5), 489-500, 2009 | 554 | 2009 |
| Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation C Toffalori, L Zito, V Gambacorta, M Riba, G Oliveira, G Bucci, M Barcella, ... Nature medicine 25 (4), 603-611, 2019 | 350 | 2019 |
| Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide A Larocca, F Cavallo, S Bringhen, F Di Raimondo, A Falanga, ... Blood, The Journal of the American Society of Hematology 119 (4), 933-939, 2012 | 347 | 2012 |
| Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer M Bregni, A Dodero, J Peccatori, A Pescarollo, M Bernardi, I Sassi, ... Blood, The Journal of the American Society of Hematology 99 (11), 4234-4236, 2002 | 265 | 2002 |
| Antitumor effects of HSV-TK–engineered donor lymphocytes after allogeneic stem-cell transplantation F Ciceri, C Bonini, S Marktel, E Zappone, P Servida, M Bernardi, ... Blood, The Journal of the American Society of Hematology 109 (11), 4698-4707, 2007 | 220 | 2007 |
| NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications A Russo, G Oliveira, S Berglund, R Greco, V Gambacorta, N Cieri, ... Blood, The Journal of the American Society of Hematology 131 (2), 247-262, 2018 | 205 | 2018 |
| Immunological outcome in haploidentical-HSC transplanted patients treated with IL-10-anergized donor T cells R Bacchetta, B Lucarelli, C Sartirana, S Gregori, MT Lupo Stanghellini, ... Frontiers in immunology 5, 16, 2014 | 172 | 2014 |
| Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation N Cieri, G Oliveira, R Greco, M Forcato, C Taccioli, B Cianciotti, ... Blood, The Journal of the American Society of Hematology 125 (18), 2865-2874, 2015 | 169 | 2015 |
| Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT M Noviello, F Manfredi, E Ruggiero, T Perini, G Oliveira, F Cortesi, ... Nature communications 10 (1), 1065, 2019 | 161 | 2019 |
| Post-transplantation cyclophosphamide and sirolimus after haploidentical hematopoietic stem cell transplantation using a treosulfan-based myeloablative conditioning and … N Cieri, R Greco, L Crucitti, M Morelli, F Giglio, G Levati, A Assanelli, ... Biology of Blood and Marrow Transplantation 21 (8), 1506-1514, 2015 | 152 | 2015 |
| Temporal, quantitative, and functional characteristics of single-KIR–positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity … L Vago, B Forno, MP Sormani, R Crocchiolo, E Zino, S Di Terlizzi, ... Blood, The Journal of the American Society of Hematology 112 (8), 3488-3499, 2008 | 147 | 2008 |
| Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation L Crucitti, R Crocchiolo, C Toffalori, B Mazzi, R Greco, A Signori, ... Leukemia 29 (5), 1143-1152, 2015 | 140 | 2015 |
| Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from … J Peccatori, A Forcina, D Clerici, R Crocchiolo, L Vago, MTL Stanghellini, ... Leukemia 29 (2), 396-405, 2015 | 136 | 2015 |
| Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory G Oliveira, E Ruggiero, MTL Stanghellini, N Cieri, M D’Agostino, R Fronza, ... Science translational medicine 7 (317), 317ra198-317ra198, 2015 | 131 | 2015 |
| Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or … DW Beelen, R Trenschel, M Stelljes, C Groth, T Masszi, P Reményi, ... The Lancet Haematology 7 (1), e28-e39, 2020 | 130 | 2020 |
| Improving the safety of cell therapy with the TK-suicide gene R Greco, G Oliveira, MTL Stanghellini, L Vago, A Bondanza, J Peccatori, ... Frontiers in pharmacology 6, 95, 2015 | 127 | 2015 |
| Autologous pancreatic islet transplantation in human bone marrow P Maffi, G Balzano, M Ponzoni, R Nano, V Sordi, R Melzi, A Mercalli, ... Diabetes 62 (10), 3523-3531, 2013 | 113 | 2013 |
